FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katerina Wolf

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Chlamydia Infections

Phenomena

Physiology

Protein Transport

Procedures

Co-author Network

Publications

TOP 3
Katerina Wolf; Kenneth A Fields
Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3.
B Chellas-Géry; Ted Hackstadt; J Tisoncik; Katerina Wolf; Kenneth A Fields
Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions.
Eugenia Silva-Herzog; Katerina Wolf; Ann K Avery; Jose A Coba; Kenneth A Fields; Sabrina S Joseph; Gregory V Plano
Scc1 (CP0432) and Scc4 (CP0033) function as a type III secretion chaperone for CopN of Chlamydia pneumoniae.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katerina Wolf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katerina Wolf; Kenneth A Fields
Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(4):1695-701.
2011: B Chellas-Géry; Ted Hackstadt; J Tisoncik; Katerina Wolf; Kenneth A Fields
Biochemical and localization analyses of putative type III secretion translocator proteins CopB and CopB2 of Chlamydia trachomatis reveal significant distinctions.
Infection and immunity 2011;79(8):3036-45.
2011: Eugenia Silva-Herzog; Katerina Wolf; Ann K Avery; Jose A Coba; Kenneth A Fields; Sabrina S Joseph; Gregory V Plano
Scc1 (CP0432) and Scc4 (CP0033) function as a type III secretion chaperone for CopN of Chlamydia pneumoniae.
Journal of bacteriology 2011;193(14):3490-6.
2011: Katerina Wolf
Is C. Pneumoniae research in peril?
Frontiers in microbiology 2011;2():56.
2009: S Hower; Katerina Wolf; Kenneth A Fields
Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
Molecular microbiology 2009;72(6):1423-37.
2009: Katerina Wolf; Gregory V Plano; Kenneth A Fields
A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1.
Cellular microbiology 2009;11(5):769-79.
2009: Helen J Betts; Katerina Wolf; Kenneth A Fields
Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal.
Current opinion in microbiology 2009;12(1):81-7.
2006: Katerina Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; Kenneth A Fields
Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Molecular microbiology 2006;61(6):1543-55.
2005: Katerina Wolf; Elizabeth Fischer; Ted Hackstadt
Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells.
Infection and immunity 2005;73(8):4560-70.
2001: Katerina Wolf; E Fischer; D Mead; Guangming Zhong; R Peeling; B Whitmire; Harlan D Caldwell
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.
Infection and immunity 2001;69(5):3082-91.
2001: Katerina Wolf; Ted Hackstadt
Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells.
Cellular microbiology 2001;3(3):145-52.
2000: X X Bin; Katerina Wolf; T Schaffner; R Malinverni
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice.
Antimicrobial agents and chemotherapy 2000;44(6):1761-4.
2000: Katerina Wolf; Elizabeth Fischer; Ted Hackstadt
Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.
Infection and immunity 2000;68(4):2379-85.
1999: Katerina Wolf; R Malinverni
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis.
Antimicrobial agents and chemotherapy 1999;43(6):1491-3.